Format

Send to

Choose Destination
Oncotarget. 2018 Aug 17;9(64):32400. doi: 10.18632/oncotarget.26017. eCollection 2018 Aug 17.

Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer?

Author information

1
Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.
2
Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.
3
Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.409.].

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center